Adalimumab in Axial Spondyloarthritis. An Investigation of Whole-body MRI, MRI of Sacroiliac Joints and Spine and Soluble Biomarkers of Joint Inflammation and Damage.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 05 Apr 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Apr 2019 Results of post hoc analysis investigating the distribution of whole-body MRI (WBMRI) inflammatory lesions of peripheral joints and entheses, published in The Journal of Rheumatology.
17 Jun 2017 Results (n=21) of US substudy, presented at the 18th Annual Congress of the European League Against Rheumatism
17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com